Free Trial

Vigil Neuroscience (VIGL) Competitors

Vigil Neuroscience logo
$8.05 0.00 (0.00%)
As of 08/5/2025

VIGL vs. NVTS, AUPH, BHVN, SDGR, DYN, EWTX, TVTX, ANIP, JANX, and WVE

Should you be buying Vigil Neuroscience stock or one of its competitors? The main competitors of Vigil Neuroscience include Navitas Semiconductor (NVTS), Aurinia Pharmaceuticals (AUPH), Biohaven (BHVN), Schrodinger (SDGR), Dyne Therapeutics (DYN), Edgewise Therapeutics (EWTX), Travere Therapeutics (TVTX), ANI Pharmaceuticals (ANIP), Janux Therapeutics (JANX), and WAVE Life Sciences (WVE).

Vigil Neuroscience vs. Its Competitors

Navitas Semiconductor (NASDAQ:NVTS) and Vigil Neuroscience (NASDAQ:VIGL) are related small-cap companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

Navitas Semiconductor has a beta of 3.02, indicating that its stock price is 202% more volatile than the S&P 500. Comparatively, Vigil Neuroscience has a beta of 3.33, indicating that its stock price is 233% more volatile than the S&P 500.

Vigil Neuroscience has lower revenue, but higher earnings than Navitas Semiconductor. Navitas Semiconductor is trading at a lower price-to-earnings ratio than Vigil Neuroscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Navitas Semiconductor$83.30M18.83-$84.60M-$0.65-11.32
Vigil NeuroscienceN/AN/A-$84.26M-$2.05-3.93

46.1% of Navitas Semiconductor shares are held by institutional investors. Comparatively, 83.6% of Vigil Neuroscience shares are held by institutional investors. 29.9% of Navitas Semiconductor shares are held by insiders. Comparatively, 18.0% of Vigil Neuroscience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Navitas Semiconductor had 9 more articles in the media than Vigil Neuroscience. MarketBeat recorded 13 mentions for Navitas Semiconductor and 4 mentions for Vigil Neuroscience. Vigil Neuroscience's average media sentiment score of 1.00 beat Navitas Semiconductor's score of 0.24 indicating that Vigil Neuroscience is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Navitas Semiconductor
3 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Vigil Neuroscience
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Navitas Semiconductor currently has a consensus target price of $5.65, suggesting a potential downside of 23.23%. Vigil Neuroscience has a consensus target price of $10.80, suggesting a potential upside of 34.16%. Given Vigil Neuroscience's higher possible upside, analysts plainly believe Vigil Neuroscience is more favorable than Navitas Semiconductor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Navitas Semiconductor
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33
Vigil Neuroscience
0 Sell rating(s)
10 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Vigil Neuroscience has a net margin of 0.00% compared to Navitas Semiconductor's net margin of -182.63%. Navitas Semiconductor's return on equity of -18.16% beat Vigil Neuroscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Navitas Semiconductor-182.63% -18.16% -16.26%
Vigil Neuroscience N/A -111.70%-74.67%

Summary

Navitas Semiconductor beats Vigil Neuroscience on 8 of the 15 factors compared between the two stocks.

Get Vigil Neuroscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for VIGL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VIGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VIGL vs. The Competition

MetricVigil NeuroscienceMED IndustryMedical SectorNASDAQ Exchange
Market Cap$383.91M$3.03B$5.54B$9.82B
Dividend YieldN/A2.27%4.62%4.11%
P/E Ratio-3.9320.6730.1526.03
Price / SalesN/A363.56461.34104.73
Price / CashN/A42.0537.7558.93
Price / Book4.607.638.496.06
Net Income-$84.26M-$54.65M$3.26B$265.11M
7 Day PerformanceN/A5.41%4.19%3.38%
1 Month Performance-0.25%7.14%4.64%2.28%
1 Year Performance175.68%31.27%35.15%29.67%

Vigil Neuroscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VIGL
Vigil Neuroscience
3.437 of 5 stars
$8.05
flat
$10.80
+34.2%
N/A$383.91MN/A-3.9340News Coverage
NVTS
Navitas Semiconductor
1.2951 of 5 stars
$8.05
+1.1%
$3.71
-53.9%
+139.0%$1.54B$83.30M-15.48160
AUPH
Aurinia Pharmaceuticals
2.2242 of 5 stars
$11.45
+9.2%
$12.00
+4.8%
+120.4%$1.51B$235.13M26.63300Positive News
High Trading Volume
BHVN
Biohaven
3.2213 of 5 stars
$14.70
-0.1%
$58.46
+297.8%
-63.3%$1.50BN/A-1.57239Trending News
Earnings Report
Analyst Forecast
SDGR
Schrodinger
3.0256 of 5 stars
$19.99
+2.4%
$32.75
+63.8%
-0.4%$1.47B$230.49M-7.60790Analyst Revision
DYN
Dyne Therapeutics
3.5752 of 5 stars
$10.25
+2.0%
$36.25
+253.7%
-72.0%$1.46BN/A-2.66100
EWTX
Edgewise Therapeutics
1.9582 of 5 stars
$13.61
-4.9%
$40.55
+197.9%
-19.7%$1.43BN/A-8.7860Earnings Report
Analyst Revision
TVTX
Travere Therapeutics
2.0663 of 5 stars
$15.96
+2.1%
$32.14
+101.4%
+104.2%$1.42B$273.53M-5.68460Analyst Revision
ANIP
ANI Pharmaceuticals
3.2686 of 5 stars
$65.43
+2.3%
$78.88
+20.5%
+50.5%$1.42B$614.38M-51.52600Earnings Report
Analyst Forecast
JANX
Janux Therapeutics
2.0073 of 5 stars
$23.91
+1.5%
$91.89
+284.3%
-34.5%$1.41B$10.59M-17.5830Earnings Report
Analyst Revision
WVE
WAVE Life Sciences
4.7722 of 5 stars
$8.75
+1.4%
$20.27
+131.6%
+57.3%$1.39B$108.30M-9.72240

Related Companies and Tools


This page (NASDAQ:VIGL) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners